El hígado graso: un trastorno heterogéneo con alta prevalencia global

El-Kassas M, Cabezas J, Coz PI, Zheng MH, Arab JP, Awad A. Nonalcoholic Fatty Liver Disease: Current Global Burden. Semin Liver Dis. 2022;42(3):401-412. https://doi.org/10.1055/a-1862-9088

Ge X, Zheng L, Wang M, Du Y, Jiang J. Prevalence trends in nonalcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study. BMJ Open. 2020;10(8):e036663. https://doi.org/10.1136/bmjopen-2019-036663

Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol 2019;70(03):531-544. https://doi.org/10.1016/j.jhep.2018.10.033

Kobayashi T, Iwaki M, Nakajima A, Nogami A, Yoneda, M. Current Research on the Pathogenesis of NAFLD/NASH and the Gut-Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome. Int J Mol Sci. 2022;23(19):11689. https://doi.org/10.3390/ijms231911689

Carvalho-Gontijo R, Han C, Zhang L, Zhang V, Hosseini M, Mekeel K, et al. Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD. Semin Liver Dis. 2022;42(3):233-249. https://doi.org/10.1055/s-0042-1755316

Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wai-Sun Wong V, Wright E, et al. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2021;161(5):1657-1669. https://doi.org/10.1053/j.gastro.2021.07.049

Prieto-Ortiz JE, Sánchez-Luque CB, Ortega-Quiróz R. Hígado graso (parte 1): aspectos generales, epidemiología, fisiopatología e historia natural. Rev Colomb Gastroenterol. 2022;37(4):420-433. https://doi.org/10.22516/25007440.952

Castera L, Boursier J. Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD. Semin Liver Dis. 2022;42(3):313-326. https://doi.org/10.1055/s-0042-1751081